Evidence map›Paper›PMID 38643461›Full record

ArticleAging2024

High-dose Vitamin C injection ameliorates against sepsis-induced myocardial injury by anti-apoptosis, anti-inflammatory and pro-autophagy through regulating MAPK, NF-κB and PI3K/AKT/mTOR signaling pathways in rats.

Ya-Nan Cui, Na Tian, Yan-Hai Luo, Ji-Jun Zhao, Cheng-Fei Bi, Yi Gou, Jia Liu, Ke Feng, Jun-Fei Zhang

Open access · hybridAbstract read
In one paragraph

Article in Aging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Effect of High-Dose Vitamin C on Tendon Cell Degeneration-An In Vitro Study.International journal of molecular sciences · 2024
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Ya-Nan CuiMedical Records and Statistics Room, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750000, China.
Na TianDepartment of Emergency Medical, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750000, China.
Yan-Hai LuoDepartment of Pathology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750000, China.
Ji-Jun ZhaoDepartment of Emergency Medical, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750000, China.
Cheng-Fei BiDepartment of Emergency Medical, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750000, China.
Yi GouDepartment of Emergency Medical, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750000, China.
Jia LiuDepartment of Emergency Medical, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750000, China.
Ke FengDepartment of Emergency Medical, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750000, China.
Jun-Fei ZhangDepartment of Emergency Medical, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750000, China.
Ningxia Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThis study aimed to evaluate the effects of VC on SIMI in rats.

methodsIn this study, the survival rate of high dose VC for SIMI was evaluated within 7 days. Rats were randomly assigned to three groups: Sham group, CLP group, and high dose VC (500 mg/kg i.v.) group. The animals in each group were treated with drugs for 1 day, 3 days or 5 days, respectively. Echocardiography, myocardial enzymes and HE were used to detect cardiac function. IL-1β, IL-6, IL-10 and TNF-α) in serum were measured using ELISA kits. Western blot was used to detect proteins related to apoptosis, inflammation, autophagy, MAPK, NF-κB and PI3K/Akt/mTOR signaling pathways.

resultsHigh dose VC improved the survival rate of SIMI within 7 days. Echocardiography, HE staining and myocardial enzymes showed that high-dose VC relieved SIMI in rats in a time-dependent manner. And compared with CLP group, high-dose VC decreased the expressions of pro-apoptotic proteins, while increased the expression of anti-apoptotic protein. And compared with CLP group, high dose VC decreased phosphorylation levels of Erk1/2, P38, JNK, NF-κB and IKK α/β in SIMI rats. High dose VC increased the expression of the protein Beclin-1 and LC3-II/LC3-I ratio, whereas decreased the expression of P62 in SIMI rats. Finally, high dose VC attenuated phosphorylation of PI3K, AKT and mTOR compared with the CLP group. SIGNIFICANCE: Our results showed that high dose VC has a good protective effect on SIMI after continuous treatment, which may be mediated by inhibiting apoptosis and inflammatory, and promoting autophagy through regulating MAPK, NF-κB and PI3K/AKT/mTOR pathway.

Indexed as

Ascorbic AcidAutophagyHeart InjuriesMyocardiumSepsisAnimalsAnti-Inflammatory AgentsApoptosisNF-kappa BPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRatsRats, Sprague-DawleySignal TransductionTOR Serine-Threonine KinasesAnti-Inflammatory AgentsAscorbic AcidmTOR protein, ratNF-kappa BPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesapoptosisautophagyHigh-dose Vitamin CinflammatoryMAPKNF-κB and PI3K/AKT/mTOR signaling pathwayssepsis-induced myocardial injury

Identifiers

PMID38643461
PMCPMC11087106
OpenAlexW4394950716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.